Treatment with resveratrol, a SIRT1 activator, ameliorates fatty liver with a reduction in the expression of lipogenic enzymes in mice exhibiting obesity and insulin resistance [34,35,36]. The gene discussed is SIRT1; the disease is obesity due to melanocortin 4 receptor deficiency.